Ullswater Investments · EU Funding News

Call alert · Horizon Europe · Cluster 1 Health

Advancing bio-printing of living cells for regenerative medicine

HORIZON-HLTH-2027-03-TOOL-02

Forthcoming · Deadline · Data checked 4 November 2026 from the EU Funding & Tenders Portal

HORIZON-HLTH-2027-03-TOOL-02 — “Advancing bio-printing of living cells for regenerative medicine” — is a forthcoming Horizon Europe call. It opens on 3 June 2027 and the deadline is 16 September 2027.

Key facts

Call identifier
HORIZON-HLTH-2027-03-TOOL-02
Programme
Horizon Europe · Cluster 1 Health
Status
Forthcoming
Opens
3 June 2027
Deadline
16 September 2027 (316 days left)
Budget
≈ €7M–€10M / project
Keywords
ATMP, Bio-Ink, Bio-Printing, Biofabrication, Bioink

Official call page

HORIZON-HLTH-2027-03-TOOL-02 on the EU Funding & Tenders Portal — eligibility conditions, topic description, expected outcomes and submission system.

Frequently asked questions

When is the deadline for HORIZON-HLTH-2027-03-TOOL-02?

The deadline is 16 September 2027. Funding & Tenders Portal deadlines usually close at 17:00 Brussels time; always confirm the exact time on the official call page.

What is the budget of HORIZON-HLTH-2027-03-TOOL-02?

The published budget is ≈ €7M–€10M / project.

Where do I apply for HORIZON-HLTH-2027-03-TOOL-02?

Proposals are submitted electronically through the EU Funding & Tenders Portal, using the link to the official call page on this page.

Other open calls in Horizon Europe · Cluster 1 Health

CallProgrammeDeadlineStatus
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-01-CARE-02Horizon Europe · Cluster 1 HealthOpen
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-05Horizon Europe · Cluster 1 HealthOpen
Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-06Horizon Europe · Cluster 1 HealthOpen
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-07Horizon Europe · Cluster 1 HealthOpen
Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-DISEASE-08Horizon Europe · Cluster 1 HealthOpen
Prevention and management of chronic non-communicable diseases in children and young people (GACD)HORIZON-HLTH-2027-01-DISEASE-10Horizon Europe · Cluster 1 HealthOpen
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-ENVHLTH-02Horizon Europe · Cluster 1 HealthOpen
Tools and technologies to support health adaptation to climate changeHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03Horizon Europe · Cluster 1 HealthOpen